About HER2-Positive Lung Cancer
If you have non-small cell lung cancer (NSCLC) and your doctor told you that you have a HER2 biomarker, this site will help you understand what your diagnosis means and how it impacts your treatment options. Use this information to help you talk with your doctor to decide the best treatment options for you.
New & Upcoming Events for Rare Mutations
Latest Updates in Rare Mutations
-
New Treatment Approved for ROS1-positive NSCLC
On July 22, 2026, the US Food and Drug Administration (FDA) announced the approval of zidesamtinib (Jideytro™) to treat patients with locally-advanced or metastatic ROS1-positive... -
Getting to the Bone of the Matter: Bone-Modifying Agents
LUNGevity offers a variety of virtual support groups called ‘meetups’ where survivors and caregivers impacted by lung cancer connect with others who understand the patient... -
Camila Bermúdez García: Turning Experience into Advocacy
Before lung cancer entered her life, 24-year-old Camila Bermudez Garcia was focused on building her future. Growing up as the oldest of three in Ponce, Puerto Rico, she was...
Sponsors
